Showing results (271-280 of 648) with videos related to

Sort By:
Pageof 65
Parasitology Research|August 22, 2000
Taxonomic position of the human intestinal protozoan parasite Isospora belli as based on ribosomal RNA sequencesC Franzen, A Müller, R Bialek, et al.
The Journal of Experimental Medicine|December 20, 2000
Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reactionM Müschen, D Re, B Jungnickel, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Detection of Isospora belli by polymerase chain reaction using primers based on small-subunit ribosomal RNA sequencesA Müller, R Bialek, G Fätkenheuer, et al.
Leukemia & Lymphoma|June 1, 1995
Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphomaD T Nguyen, L W Diamond, M Schwonzen, et al.
Histology and Histopathology|January 1, 2004
Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosisJ Thiele, H M Kvasnicka, A Schmitt-Gräff, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 1, 1992
[NMR tomography in plasmacytoma]A Linden, C Gückel, R Widder, et al.
Leukemia Research|January 1, 1986
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profilesH G Drexler, G Gaedicke, M S Lok, et al.
International Journal of Cancer|September 30, 1991
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in miceA Engert, G Martin, P Amlot, et al.
European Journal of Nuclear Medicine|January 1, 1989
Bone marrow investigation with technetium-99m microcolloid and magnetic resonance imaging in patients with malignant myelolympho-proliferative diseasesA Widding, J Smolorz, M Franke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's diseaseB Kniep, D A Monner, H Burrichter, et al.
Pageof 65